In the Press: The Elizabeth Holmes Trial (Wall Street Journal)
September 2021 – Theranos Inc. founder Elizabeth Holmes is facing a criminal trial in federal court in San Jose, Calif., on charges that she defrauded investors and patients by lying about the accuracy of her company’s finger-prick blood-testing technology. Holmes has pleaded not guilty to charges of wire fraud and conspiracy to commit wire fraud.
The former Theranos CEO has adopted a soft new look—which diverges from her previous black-turtleneck uniform—as a defendant in her criminal trial. FLC Senior Trial Consultant, Dr. Geri Fischman, spoke with the Wall Street Journal about personal branding and trial image in financial fraud cases.
WSJ subscribers can access the arcticle here.
The article is available for non-subscribers below: